• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 15th June 2018

OHE at HESG, AES and PROMs Summer 2018

Meet some of the OHE team at any of three conferences taking place from 20-22 June: HESG, AES, and the PROMS Research Conference. Meet some of the OHE team at any of three conferences taking place from 20-22 June: the…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

Meet some of the OHE team at any of three conferences taking place from 20-22 June: HESG, AES, and the PROMS Research Conference.

Meet some of the OHE team at any of three conferences taking place from 20-22 June: the UK Health Economists’ Study Group (HESG), the Spanish Health Economics Association (AES), and the PROMS Research Conference.
 
This year’s summer HESG meeting will be hosted by the University of Bristol and will take place 20-22 June at Mercure Bristol Holland House. OHE’s Paula Lorgelly, David Mott, and Chris Sampson will all be contributing to the proceedings.
 
Plenary: Opportunities and Challenges of Brexit for Health Economists
 
[Wednesday, 18:30-19:30, Forest Room]
 
The summer 2018 HESG plenary will be on the subject of ‘Brexit’ and will be delivered by Paula, Ellen Rule, and Andrew Street.
 
Paper: Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
 
[Wednesday, 15:30-16:25, Birch]
 
David’s paper on the generation of an EQ-5D-Y value set will be discussed at the conference by Caroline Clarke. The paper describes an online survey with a representative sample of adults and a representative sample of adolescents, enabling the authors to compare preferences between the groups.
 
 
Paper: Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Time? A Longitudinal Study of Cancer Patients
 
[Thursday, 14:30-15:25, Birch]
 
Paula’s paper, which will be discussed by Annie Hawton, describes an analysis of data from a cohort of cancer patients that switched from using the EQ-5D-3L to the EQ-5D-5L. The study provides insights into the implications of using the EQ-5D-5L instead of the EQ-5D-3L, and how this could influence the estimation of treatment effects. 
 
Members of the OHE team will also chair and discuss at sessions for other delegates’ papers, including:
  • Discussion: Measuring QALYs When Health States Fluctuate (Sanghera & Coast)
  • Discussion: A Novel Way of Anchoring Discrete Choice Experiments Valuing EQ-5D Health States (Webb et al)
  • Chair: Exploring the Factors That Influence Workforce Participation of People with Multiple Sclerosis: A Discrete Choice Experiment (Goodwin et al)

The theme for the 38th edition of the Spanish Health Economics Association Conference is “Sharing decisions: What changes are needed?”. The conference takes place 20-22 June in Las Palmas de Gran Canaria and will be attended by Patricia Cubi-Molla and Mikel Berdud.

 
Poster Session: Quality of Life and Preferences
 
[Wednesday, 13:15-14:15, Tenerife]
 
Patricia will moderate this poster session exploring quality of life in different patient groups and preferences for different health care services.
 
Oral presentation: R&D, Competition and Diffusion of Innovation in the EU: The Case of Direct Acting Antivirals (DAAs) for Hepatitis C
 
[Wednesday, 15:15-16:45, Gran Canaria]
 
Mikel will present on the role of incentives for R&D and market competition in access to DAAs in Europe, as well as the potential additional factors including health system capacity, healthcare policies and societal barriers that could also affect access.
 
Panel Session: Evaluation of Health Policies and Services
 
[Thursday, 11:30-13:00, Tenerife]
 
Patricia will chair this panel session organised on behalf of EvaluAES. The session will include research on economic evaluation and health technology assessment in a variety of settings.
 
Oral Presentation: Comparing the EQ-5D-3L and EQ-5D-5L in a Cohort of Cancer Patients
 
[Thursday, 16:15-17:45, La Palma]
 
This presentation, delivered by Patricia, will describe ongoing work exploring the consequences of adopting the EQ-5D-5L (rather than the EQ-5D-3L) in the context of treatments for cancer.
 
Oral Presentation: Estimating the Effect of Personal Experience and Vicarious Experience on Time Trade-off Valuations of Health States: A Multi-country Comparison
 
[Thursday, 16:15-17:45, La Palma]
 
Patricia will also present on research that seeks to estimate the effect of different forms of experience on health state valuations following the time trade-off (TTO) protocol. The analysis uses the TTO value sets for EQ-5D-3L health profiles of UK, Netherlands, Denmark and Spain.
 
Other sessions at AES with OHE’s work, presented by collaborators, include:
  • Oral Presentation: Adapting to Health States: Evidence from the English Longitudinal Study of Ageing (ELSA)
  • Poster Presentation: Issues on the Estimation of the Opportunity Cost Threshold Value
  • Oral Presentation: Estimating Latent Scale Utilities to Develop and EQ-5D-Y Value Set in the UK: A Comparison of Discrete Choice Models

The PROMS Research Conference will be hosted by the Centre for Patient Reported Outcomes Research at the University of Birmingham on 20 June. Koonal Shah and Amanda Cole will both deliver oral presentations.

 
Oral Presentation: Valuing the EQ-5D-Y Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
 
[12:25, WG05]
 
Koonal will discuss findings from this ongoing study, comparing values derived for EQ-5D-Y states using preference data from adults and from adolescents.
 
Oral Presentation: What Outcomes Matter in Cancer? A Literature Review
 
[14:15, WG05]
 
Amanda will present research seeking to understand what outcomes are important to patients with cancer, including clinical measures, social outcome measures (e.g. return to work), patient-reported outcome measures (PROMs) including patient reported experience measures, or other patient defined measures.
  • Research
  • Economics of Innovation
  • Events

Related News

MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
  • News
  • January 2020

OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?

Read more
  • News
  • September 2019

OHE Lunchtime Seminar: Closing the ‘Know-do’ Gap for Health Systems Reform at the Policy Level

Read more
  • News
  • August 2019

OHE Lunchtime Seminar: How Do We Measure the ‘Value’ in Value-based Care?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!